Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by difficulty in breathing, coughing, and sputum production. It is a leading cause of morbidity and mortality worldwide, necessitating an in-depth understanding of its diagnosis and treatment strategies among healthcare professionals.
Diagnosis of COPD primarily involves identifying symptoms and risk factors, followed by spirometry to confirm airflow obstruction. The presence of a post-bronchodilator FEV1/FVC ratio of less than 0.70 confirms persistent airflow limitation and thus COPD. High-resolution computed tomography (HRCT) can be used in doubtful cases or for phenotyping.
The mainstay of COPD treatment is bronchodilator therapy, including long-acting beta-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs). Inhaled corticosteroids (ICS) are reserved for frequent exacerbators with eosinophilic inflammation. Pulmonary rehabilitation, oxygen therapy, and lifestyle modifications are also integral parts of management.
Acute exacerbations, characterized by an acute worsening of respiratory symptoms, require prompt treatment with bronchodilators, corticosteroids, and antibiotics. Non-invasive ventilation is beneficial in cases of acute respiratory failure. Early hospitalization is recommended for severe exacerbations.
Emerging therapies for COPD include dual bronchodilation, roflumilast for chronic bronchitis phenotype, and endobronchial valves for severe emphysema. Research into novel therapies like stem cell therapy and gene therapy is ongoing.
In conclusion, COPD is a complex disease requiring a comprehensive approach to diagnosis and treatment. A clear understanding of the disease pathology, diagnostic modalities, and treatment strategies is essential for healthcare professionals to manage this condition effectively and improve patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation